Brief: Biote Q4 Adjusted EBITDA USD 15.1 Million Vs. IBES Estimate USD 16 Million
Mar 12 (Reuters) - Biote Q4 adjusted EBITDA margin 30.3%. Q4 operating income USD 2.8 million vs. IBES estimate USD 10.6 million Q4 gross margin 71.8% Q4 revenue USD 49.8 million vs. IBES estimate USD 51.2 million outlook FY revenue USD 202-208 million outlook FY adjusted EBITDA USD 59-64 million
Recent news on biote
See all newsBiote Corp reports results for the quarter ended September 30 - Earnings Summary
Corrected: Biote Q3 revenue falls misses analyst expectations on soft procedure segment
Biote Corp expected to post earnings of 4 cents a share - Earnings Preview
Brief: Biote Names Bob Peterson As Interim CEO
Biote Q1 revenue falls